MX2008015640A - Compuestos para el tratamiento de trastornos metabolicos. - Google Patents

Compuestos para el tratamiento de trastornos metabolicos.

Info

Publication number
MX2008015640A
MX2008015640A MX2008015640A MX2008015640A MX2008015640A MX 2008015640 A MX2008015640 A MX 2008015640A MX 2008015640 A MX2008015640 A MX 2008015640A MX 2008015640 A MX2008015640 A MX 2008015640A MX 2008015640 A MX2008015640 A MX 2008015640A
Authority
MX
Mexico
Prior art keywords
diabetes
group
treatment
obesity
phenylacetic acid
Prior art date
Application number
MX2008015640A
Other languages
English (en)
Spanish (es)
Inventor
Shalini Sharma
Borstel Reid W Von
Original Assignee
Wellstat Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellstat Therapeutics Corp filed Critical Wellstat Therapeutics Corp
Publication of MX2008015640A publication Critical patent/MX2008015640A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2008015640A 2006-06-09 2007-06-08 Compuestos para el tratamiento de trastornos metabolicos. MX2008015640A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80433606P 2006-06-09 2006-06-09
PCT/US2007/070691 WO2007146768A2 (en) 2006-06-09 2007-06-08 Compounds for the treatment of metabolic disorders

Publications (1)

Publication Number Publication Date
MX2008015640A true MX2008015640A (es) 2009-01-09

Family

ID=38832700

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008015640A MX2008015640A (es) 2006-06-09 2007-06-08 Compuestos para el tratamiento de trastornos metabolicos.

Country Status (12)

Country Link
US (1) US20100234464A1 (https=)
EP (1) EP2026659A4 (https=)
JP (1) JP5252585B2 (https=)
KR (1) KR101391905B1 (https=)
CN (1) CN101466266A (https=)
AU (1) AU2007257854B2 (https=)
CA (1) CA2654530A1 (https=)
IL (1) IL195392A0 (https=)
MX (1) MX2008015640A (https=)
NZ (1) NZ573031A (https=)
WO (1) WO2007146768A2 (https=)
ZA (1) ZA200809774B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016027157A1 (en) 2014-08-21 2016-02-25 Daphot Enterprises Limited Peptide for treatment of type 2 diabetes mellitus and its complications

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090176885A1 (en) * 2006-02-02 2009-07-09 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
EP2240024A4 (en) * 2008-01-15 2014-05-21 Wellstat Therapeutics Corp COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
UA109638C2 (uk) 2008-03-13 2015-09-25 Сполуки та спосіб зниження рівня сечової кислоти
CN119403529A (zh) 2022-07-01 2025-02-07 国立大学法人东京大学 体表面溃疡治愈促进装置

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1354602B1 (en) * 2000-12-26 2006-10-04 Sankyo Company, Limited Medicinal compositions containing diuretic and insulin resistance-improving agent
CN101444496B (zh) * 2001-06-12 2011-04-13 维尔斯达医疗公司 用于治疗代谢失调的化合物
EP1556085A4 (en) * 2002-11-01 2012-08-22 Wellstat Therapeutics Corp COMPOUNDS FOR THE TREATMENT OF METABOLISM
CN1750758B (zh) * 2003-02-13 2012-06-20 维尔斯达医疗公司 用于治疗代谢紊乱的化合物
RU2358722C2 (ru) * 2003-04-15 2009-06-20 Веллстат Терапьютикс Корпорейшн Соединения для лечения метаболических расстройств
US7361686B2 (en) * 2003-04-22 2008-04-22 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
JP4837557B2 (ja) * 2003-04-30 2011-12-14 ウェルスタット セラピューティクス コーポレイション 代謝障害の処置のための化合物
EP1656127B1 (en) * 2003-08-20 2011-03-23 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
JP2009528275A (ja) * 2006-01-25 2009-08-06 ウェルスタット セラピューティクス コーポレイション 代謝障害を処置するための化合物
WO2007087505A2 (en) * 2006-01-25 2007-08-02 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016027157A1 (en) 2014-08-21 2016-02-25 Daphot Enterprises Limited Peptide for treatment of type 2 diabetes mellitus and its complications
US9868773B2 (en) 2014-08-21 2018-01-16 Daphot Enterprises Limited Peptide for treatment of type 2 diabetes mellitus and its complications

Also Published As

Publication number Publication date
AU2007257854B2 (en) 2012-04-12
KR101391905B1 (ko) 2014-05-07
ZA200809774B (en) 2010-10-27
AU2007257854A1 (en) 2007-12-21
CA2654530A1 (en) 2007-12-21
EP2026659A2 (en) 2009-02-25
JP5252585B2 (ja) 2013-07-31
WO2007146768A2 (en) 2007-12-21
KR20090018795A (ko) 2009-02-23
IL195392A0 (en) 2009-08-03
JP2009539877A (ja) 2009-11-19
US20100234464A1 (en) 2010-09-16
NZ573031A (en) 2011-11-25
CN101466266A (zh) 2009-06-24
EP2026659A4 (en) 2010-06-30
WO2007146768A3 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
US8044243B2 (en) Compounds for the treatment of metabolic disorders
US7645772B2 (en) Treatment of metabolic disorders
US7442796B2 (en) Compounds for the treatment of metabolic disorders
RU2420276C2 (ru) Соединения для лечения метаболических нарушений
JP2009537559A (ja) 代謝障害の処置のための化合物
JP2009531288A5 (https=)
JP4697973B2 (ja) 代謝障害の処置のための化合物
JP4703563B2 (ja) 代謝障害を治療するための化合物
AU2007257854B2 (en) Compounds for the treatment of metabolic disorders
HK1083462B (en) Compounds for the treatment of metabolic disorders
HK1087040B (en) Compounds for the treatment of metabolic disorders

Legal Events

Date Code Title Description
FG Grant or registration